AMD at CES 2025 press conference kicks off on January 6 at 11:00am to 11:45am PT, tune in for RDNA 4 unveiling, new Zen CPUs, ...

Belantamab mafodotin is under clinical development by GSK and currently in Phase I for Systemic Lupus Erythematosus.

With significant developments in AI, automotive tech and computing innovation, here are some themes you can expect to see ...

I recently watched an episode of one of my favourite TV shows, the Good Doctor. The episode revolved around how a man named Wyatt was rushed into the ER as he had a perforated valve and needed ...

It is hard to overestimate the importance of antibodies in the frameworks of biotechnology and pharmaceutical industries.

Hyundai Mobis, meanwhile, has said it will be giving us a look at its "Holographic Windshield Display, " something it's ...

The tech world always begins the new year with a sprint, making a fast-paced series of announcements at the industry’s ...

Anifrolumab is under clinical development by AstraZeneca and currently in Phase III for Polymyositis. According to GlobalData, Phase III drugs for Polymyositis does not have sufficient historical data ...

AMD, Intel, and possibly Qualcomm all have next-gen CPU launches planned for CES 2025. Here's what been rumored, confirmed, ...

There are plenty of questions out there about the potential dangers of AI. This story involving Google's Gemini AI certainly ...

AMD has a whole host of exciting hardware launches in the pipeline, from RDNA 4 graphics cards to Strix Halo APUs.

And with NVIDIA's CEO as the keynote speaker, we expect the GeForce RTX 50 series to be announced at the event. NVIDIA is ...